Article
Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions
2022-06-23
Abstract excerpt
<h4>ABSTRACT</h4> Precision oncology programs can rapidly identify oncogenic gene fusions in individual patients 1–3 . However, despite their established oncogenic status, the vast majority of gene fusions remain ‘ undruggable ’ due to the lack of specific inhibitory molecules 4, 5 . Here, we establish Psp Cas13b, a poorly characterized programmable RNA nuclease, as a versatile tool to silence various oncogen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 332fbd9f-0dc9-5de2-9c29-7bf19c17a4cc
- DOI
- 10.1101/2022.06.22.497105
